Clinical Trial Update: Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding [Phase 3]

View source ↗

Summary

Phase 3 trial update from Bayer reports efficacy and safety results for the treatment of dysfunctional uterine bleeding (metrorrhagia), with results posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysfunctional Uterine Bleeding

Drugs mentioned

• Not disclosed

Snippet

Sponsor: Bayer | Conditions: Metrorrhagia | Phase 3 | Status: COMPLETED | Results posted: 2011-06-06